Core Laboratories
CLB
355 hedge funds and large institutions have $5.49B invested in Core Laboratories in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 134 increasing their positions, 122 reducing their positions, and 42 closing their positions.
56% more call options, than puts
Call options by funds: $25M | Put options by funds: $16M
10% more repeat investments, than reductions
Existing positions increased: 134 | Existing positions reduced: 122
5% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 42
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less funds holding
Funds holding: 356 → 355 (-1)
3% less capital invested
Capital invested by funds: $5.64B → $5.49B (-$150M)
1.84% less ownership
Funds ownership: 116.81% → 114.97% (-1.8%)
Top Buyers
Top Sellers
CLB Hedge Fund Activity: Q1 2018 in Review
355 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q1 2018, worth a combined $5.49B — down 2.7% from $5.64B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new CLB positions and 42 closed out — a net gain of 2 holders — while 134 added to existing stakes and 122 trimmed.
The largest buyer was Fisher Asset Management, opening a new position worth an estimated $48.5M. The largest seller was Sustainable Growth Advisers, cutting an estimated $133M.
- 355 institutional investors held Core Laboratories (CLB) as of Q1 2018, down from 356 in Q4 2017.
- Funds reported $5.49B of Core Laboratories stock for Q1 2018, down 2.7% quarter-over-quarter.
- 44 funds opened new Core Laboratories positions in Q1 2018 and 42 closed out, a net change of +2 holders.
- The largest Core Laboratories buyer in Q1 2018 was Fisher Asset Management, an estimated $48.5M added.
- The largest Core Laboratories seller in Q1 2018 was Sustainable Growth Advisers, an estimated $133M sold.
Based on aggregated 13F filings for Q1 2018.